Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Leahy CI"'
Autor:
AM, Ross, Leahy CI, Neylon F, Steigerova J, Flodr P, Navratilova M, Urbankova H, Vrzalikova K, Mundo L, Lazzi S, Leoncini L, Pugh M, PG, Murray
Epstein–Barr virus (EBV), defined as a group I carcinogen by the World Health Organization (WHO), is present in the tumour cells of patients with different forms of B-cell lymphoma, including Burkitt lymphoma, Hodgkin lymphoma, post-transplant lymp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4427e0154fb6060065d26cf210583fbb
Autor:
Gunawardana J; Blood Cancer Research Group, Mater Research, Translational Research Institute, University of Queensland, Brisbane, Queensland, Australia., Law SC; Blood Cancer Research Group, Mater Research, Translational Research Institute, University of Queensland, Brisbane, Queensland, Australia., Sabdia MB; Blood Cancer Research Group, Mater Research, Translational Research Institute, University of Queensland, Brisbane, Queensland, Australia., Fennell É; School of Medicine, Limerick Digital Cancer Research Centre, Health Research Institute and Bernal Institute, University of Limerick, Limerick, Ireland., Hennessy A; School of Medicine, Limerick Digital Cancer Research Centre, Health Research Institute and Bernal Institute, University of Limerick, Limerick, Ireland., Leahy CI; School of Medicine, Limerick Digital Cancer Research Centre, Health Research Institute and Bernal Institute, University of Limerick, Limerick, Ireland., Murray PG; School of Medicine, Limerick Digital Cancer Research Centre, Health Research Institute and Bernal Institute, University of Limerick, Limerick, Ireland.; Royal College of Surgeons Ireland, Adliya, Bahrain., Bednarska K; Blood Cancer Research Group, Mater Research, Translational Research Institute, University of Queensland, Brisbane, Queensland, Australia., Brosda S; Frazer Institute, Translational Research Institute, University of Queensland, Brisbane, Queensland, Australia., Trotman J; Concord Repatriation General Hospital, University of Sydney, Sydney, New South Wales, Australia.; Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia., Berkahn L; Department of Haematology, Auckland City Hospital, Auckland, New Zealand., Zaharia A; Blood Cancer Research Group, Mater Research, Translational Research Institute, University of Queensland, Brisbane, Queensland, Australia., Birch S; Princess Alexandra Hospital, Brisbane, Queensland, Australia., Burgess M; School of Medicine, Limerick Digital Cancer Research Centre, Health Research Institute and Bernal Institute, University of Limerick, Limerick, Ireland.; Princess Alexandra Hospital, Brisbane, Queensland, Australia., Talaulikar D; Haematology Translational Research Unit, ACT Pathology, Canberra Health Services, Canberra, Australian Capital Territory, Australia.; College of Health and Medicine, Australian National University, Canberra, Australian Capital Territory, Australia., Lee JN; Blood Cancer Research Group, Mater Research, Translational Research Institute, University of Queensland, Brisbane, Queensland, Australia., Jude E; Austin Health, Heidelberg, Victoria, Australia., Hawkes EA; Olivia Newton John Cancer Research and Wellness Centre, Austin Health, Melbourne, Victoria, Australia.; Transfusion Research Unit, School of Public Health and Preventative Medicine, Monash University, Melbourne, Victoria, Australia., Jain S; Anatomical Pathology Department, The Canberra Hospital, Canberra, Australian Capital Territory, Australia., Nath K; Blood Cancer Research Group, Mater Research, Translational Research Institute, University of Queensland, Brisbane, Queensland, Australia.; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Snell C; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Mater Pathology, Brisbane, Queensland, Australia., Swain F; Royal College of Surgeons Ireland, Adliya, Bahrain.; Princess Alexandra Hospital, Brisbane, Queensland, Australia., Tobin JWD; Blood Cancer Research Group, Mater Research, Translational Research Institute, University of Queensland, Brisbane, Queensland, Australia.; Princess Alexandra Hospital, Brisbane, Queensland, Australia., Keane C; Frazer Institute, Translational Research Institute, University of Queensland, Brisbane, Queensland, Australia.; Princess Alexandra Hospital, Brisbane, Queensland, Australia., Shanavas M; Blood Cancer Research Group, Mater Research, Translational Research Institute, University of Queensland, Brisbane, Queensland, Australia., Blyth E; Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia.; Department of Haematology, Westmead Hospital, Westmead, New South Wales, Australia.; Westmead Institute for Medical Research, The University of Sydney, Westmead, New South Wales, Australia., Steidl C; British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Savage K; British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Farinha P; British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Boyle M; British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Meissner B; British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Green MR; MD Anderson Cancer Center, Houston, Texas, USA., Vega F; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gandhi MK; Blood Cancer Research Group, Mater Research, Translational Research Institute, University of Queensland, Brisbane, Queensland, Australia.; Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Publikováno v:
American journal of hematology [Am J Hematol] 2024 Nov; Vol. 99 (11), pp. 2096-2107. Date of Electronic Publication: 2024 Aug 17.
Autor:
Siciliano MC; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Bertolazzi G; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy.; Department of Economics, Business, and Statistics, University of Palermo, Palermo, Italy., Morello G; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy., Tornambè S; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Del Corvo M; Istituto Europeo di Oncologia (IEO), IRCSS Milano, Milan, Italy., Granai M; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Sapienza MR; Istituto Europeo di Oncologia (IEO), IRCSS Milano, Milan, Italy., Leahy CI; School of Medicine, Bernal Institute, Health Research Institute and Limerick Digital Cancer Research Centre, University of Limerick, Limerick, Ireland., Fennell E; School of Medicine, Bernal Institute, Health Research Institute and Limerick Digital Cancer Research Centre, University of Limerick, Limerick, Ireland., Belmonte B; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy., Arcuri F; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Vannucchi M; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Mancini V; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Guazzo R; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Boccacci R; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Onyango N; Department of Medical Microbiology and Immunology, University of Nairobi, Nairobi, Kenya., Nyagol J; Department of Human Pathology, University of Nairobi, Nairobi, Kenya., Santi R; Department of Pathology, University of Florence, Florence, Italy., Di Stefano G; Department of Pathology, University of Florence, Florence, Italy., Ferrara D; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Bellan C; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Marafioti T; Department of Cellular Pathology, University College London, London, United Kingdom., Ott G; AbteilungfürKlinischePathologie, Robert-Bosch-Krankenhaus and Dr. Margarete Fischer-Bosch InstitutfürKlinischePharmakologie, Stuttgart, Germany., Siebert R; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany., Quintanilla-Fend L; Institut für Pathologie und Neuropathologie, University of Tubingen, Tubingen, Germany., Fend F; Institut für Pathologie und Neuropathologie, University of Tubingen, Tubingen, Germany., Murray P; School of Medicine, Bernal Institute, Health Research Institute and Limerick Digital Cancer Research Centre, University of Limerick, Limerick, Ireland., Tripodo C; School of Medicine, Bernal Institute, Health Research Institute and Limerick Digital Cancer Research Centre, University of Limerick, Limerick, Ireland.; Tumor and Microenvironment Histopathology Unit, IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy., Pileri S; Istituto Europeo di Oncologia (IEO), IRCSS Milano, Milan, Italy., Lazzi S; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Leoncini L; Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Publikováno v:
Blood advances [Blood Adv] 2024 Aug 27; Vol. 8 (16), pp. 4330-4343.
Autor:
Ross AM; Health Research Institute and School of Medicine, University of Limerick, V94 T9PX Limerick, Ireland.; BioScience and BioEngineering Research (BioSciBer), Bernal BioMaterials Cluster, Bernal Institute, University of Limerick, V94 T9PX Limerick, Ireland., Leahy CI; Health Research Institute and School of Medicine, University of Limerick, V94 T9PX Limerick, Ireland.; BioScience and BioEngineering Research (BioSciBer), Bernal BioMaterials Cluster, Bernal Institute, University of Limerick, V94 T9PX Limerick, Ireland., Neylon F; Health Research Institute and School of Medicine, University of Limerick, V94 T9PX Limerick, Ireland.; BioScience and BioEngineering Research (BioSciBer), Bernal BioMaterials Cluster, Bernal Institute, University of Limerick, V94 T9PX Limerick, Ireland., Steigerova J; Department of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olmouc, 775 15 Olomouc, Czech Republic., Flodr P; Department of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olmouc, 775 15 Olomouc, Czech Republic.; Department of Clinical and Molecular Pathology, University Hospital Olomouc, 779 00 Olomouc, Czech Republic., Navratilova M; Department of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olmouc, 775 15 Olomouc, Czech Republic.; Department of Clinical and Molecular Pathology, University Hospital Olomouc, 779 00 Olomouc, Czech Republic., Urbankova H; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky Univesity and University Hospital Olomouc, 779 00 Olomouc, Czech Republic., Vrzalikova K; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK., Mundo L; Health Research Institute and School of Medicine, University of Limerick, V94 T9PX Limerick, Ireland.; Department of Medical Biotechnologies, Section of Pathology, University of Siena, 53100 Siena, Italy., Lazzi S; Department of Medical Biotechnologies, Section of Pathology, University of Siena, 53100 Siena, Italy., Leoncini L; Department of Medical Biotechnologies, Section of Pathology, University of Siena, 53100 Siena, Italy., Pugh M; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK., Murray PG; Health Research Institute and School of Medicine, University of Limerick, V94 T9PX Limerick, Ireland.; Department of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olmouc, 775 15 Olomouc, Czech Republic.
Publikováno v:
Life (Basel, Switzerland) [Life (Basel)] 2023 Feb 14; Vol. 13 (2). Date of Electronic Publication: 2023 Feb 14.
Autor:
Ross AM; BioScience and Bioengineering Research (BioSciBer), Bernal Biomaterials, Bernal Institute, University of Limerick, Limerick, Ireland; School of Engineering, University of Limerick, Limerick, Ireland., Kennedy T; Department of Chemical Sciences, University of Limerick, Limerick, Ireland., McNulty D; Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland., Leahy CI; BioScience and Bioengineering Research (BioSciBer), Bernal Biomaterials, Bernal Institute, University of Limerick, Limerick, Ireland; Health Research Institute, (HRI), University of Limerick, Limerick, Ireland; Education and Health Sciences, University of Limerick, Limerick, Ireland., Walsh DR; BioScience and Bioengineering Research (BioSciBer), Bernal Biomaterials, Bernal Institute, University of Limerick, Limerick, Ireland; School of Engineering, University of Limerick, Limerick, Ireland., Murray P; BioScience and Bioengineering Research (BioSciBer), Bernal Biomaterials, Bernal Institute, University of Limerick, Limerick, Ireland; Health Research Institute, (HRI), University of Limerick, Limerick, Ireland; Education and Health Sciences, University of Limerick, Limerick, Ireland., Grabrucker AM; BioScience and Bioengineering Research (BioSciBer), Bernal Biomaterials, Bernal Institute, University of Limerick, Limerick, Ireland; Health Research Institute, (HRI), University of Limerick, Limerick, Ireland; Department of Biological Sciences, University of Limerick, Limerick, Ireland., Mulvihill JJE; BioScience and Bioengineering Research (BioSciBer), Bernal Biomaterials, Bernal Institute, University of Limerick, Limerick, Ireland; School of Engineering, University of Limerick, Limerick, Ireland; Health Research Institute, (HRI), University of Limerick, Limerick, Ireland. Electronic address: john.mulvihill@ul.ie.
Publikováno v:
Materials science & engineering. C, Materials for biological applications [Mater Sci Eng C Mater Biol Appl] 2020 Aug; Vol. 113, pp. 110985. Date of Electronic Publication: 2020 Apr 23.